Immune responses to herpesviral vectors

Human Gene Therapy

Volumn 20, Issue 5, 2009, Pages 434-441

  Ryan, Deborah A ^a   Federoff, Howard J ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; HERPESVIRUS VECTOR; QS 21; TOLL LIKE RECEPTOR; VIRUS DNA; VIRUS GLYCOPROTEIN;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; AMPLICON; CLINICAL TRIAL; DNA PACKAGING; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INNATE IMMUNITY; LIFE CYCLE; NONHUMAN; REVIEW; TRANSGENE; VACCINATION; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS RECOMBINANT;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, VIRAL; CYTOKINES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNITY, INNATE; SIMPLEXVIRUS; TOLL-LIKE RECEPTORS;

EID: 66149104617     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.019     Document Type: Review

References (66)

1. Ankel, H., Westra, D.F., Welling-Wester, S., and Lebon, P. (1998). Induction of interferon-α by glycoprotein D of herpes simplex virus: A possible role of chemokine receptors. Virology 251, 317-326.
2. Aravalli, R.N., Hu, S., Rowen, T.N., Palmquist, J.M., and Lokensgard, J.R. (2005). Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J. Immunol. 175, 4189-4193.
3. Bowers, W.J., Mastrangelo, M.A., Stanley, H.A., Casey, A.E., Milo, L.J., Jr., and Federoff, H.J. (2005). HSV amplicon-mediated Aβ vaccination in Tg2576 mice: Differential antigen-specific immune responses. Neurobiol. Aging 26, 393-407.
4. Croen, K.D., Ostrove, J.M., Dragovic, L.J., Smialek, J.E., and Strauss, S.E. (1987). Latent herpes simplex virus in human trigeminal ganglia. N. Engl. J. Med. 317, 1427-1432.
5. Da Costa, X.J., Brockman, M.A., Alicot, E., Ma, M., Fischer, M.B., Zhou, X., Knipe, D.M., and Carroll, M.C. (1999). Humoral response to herpes simplex virus is complement-dependent. Proc. Natl. Acad. Sci. U.S.A. 96, 12708-12712.
6. DeLuca, N.A., McCarthy, A.M., and Schaffer, P.A. (1985). Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56, 558-570.
7. DeLuca, N.A., and Schaffer, P.A. (1987). Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res. 15, 4491-4511.
8. Dolan, A., Jamieson, F.E., Cunningham, C., Barnett, B.C., and McGeoch, D.J. (1998). The genome sequence of herpes simplex virus type 2. J. Virol. 72, 2010-2021.
9. Dowler, K.W., and Veltri, R.W. (1984). In vitro neutralization of HSV-2: Inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR). J. Med. Virol. 13, 251-259.
10. Fraefel, C., Song, S., Lim, F., Lang, P., Yu, L., Wang, Y., Wild, P., and Geller, A.I. (1996). Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70, 7190-7197.
11. Frampton, A.R., Jr., Goins, W.F., Nakano, K., Burton, E.A., and Glorioso, J.C. (2005). HSV trafficking and development of gene therapy vectors with applications in the nervous system. Gene Ther. 12, 891-901.
12. Geller, A.I., Keyomarsi, K., Bryan, J., and Pardee, A.B. (1990). An efficient deletion mutant packaging system for defective herpes simplex virus vectors: Potential applications to human gene therapy and neuronal physiology. Proc. Natl. Acad. Sci. U.S.A. 87, 8950-8954.
13. Geraghty, R.J., Krummenacher, C., Cohen, G.H., Eisenberg, R.J., and Spear, P.G. (1998). Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280, 1618-1620.
14. Gruenheid, S., Gatzke, L., Meadows, H., and Tufaro, F. (1993). Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J. Virol. 67, 93-100.
15. Grunewald, K., Desai, P., Winkler, D.C., Heymann, J.B., Belnap, D.M., Baumeister, W., and Steven, A.C. (2003). Three-dimensional structure of herpes simplex virus from cryoelectron tomography. Science 302, 1396-1398.
16. Herold, B.C., WuDunn, D., Soltys, N., and Spear, P.G. (1991). Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J. Virol. 65, 1090-1098.
17. Hock, C., Konietzko, U., Streffer, J.R., Tracy, J., Signorell, A., Mü ller-Tillmanns, B., Lemke, U., Henke, K., Moritz, E., Garcia, E., Wollmer, M.A., Umbricht, D., de Quervain, D.J., Hofmann, M., Maddalena, A., Papassotiropoulos, A., and Nitsch, R.M. (2003). Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease. Neuron 38, 547-554.
18. Homa, F.L., and Brown, J.C. (1997). Capsid assembly and DNA packaging in herpes simplex virus. Rev. Med. Virol. 7, 107-122.
19. Johnson, P.A., Miyanohara, A., Levine, F., Cahill, T., and Friedmann, T. (1992a). Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol. 66, 2952-2965.
20. Johnson, P.A., Miyanohara, A., Levine, F., Cahill, T., and Friedmann, T. (1992b). Cytotoxicity of a replication-defective mutant of herpes simplex virus type I. J. Virol. 66, 2952-2965.
21. Johnson, R.M., Lancki, D.W., Sperling, A.I., Dick, R.F., Spear, P.G., Fitch, F.W., and Bluestone, J.A. (1992). A murine CD4-, CD8- T cell receptor-γδ T lymphocyte clone specific for herpes simplex virus glycoprotein I. J. Immunol. 148, 983-988.
22. + cytotoxic regulatory T cells. Blood 107, 1031-1038.
23. Krisky, D.M., Wolfe, D., Goins, W.F., Marconi, P.C., Ramakrishnan, R., Mata, M., Rouse, R.J., Fink, D.J., and Glorioso, J.C. (1998). Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits longterm gene expression in neurons. Gene Ther. 5, 1593-1603.
24. Krug, A., Luker, G.D., Barchet, W., Leib, D.A., Akira, S., and Colonna, M. (2004). Herpes simplex virus type 1 activates murine natural interferon-producing cells through Toll-like receptor 9. Blood 103, 1433-1437.
25. Krummenacher, C., Rux, A.H., Whitbeck, J.C., Ponce-de-Leon, M., Lou, H., Baribaud, I., Hou, W., Zou, C., Geraghty, R.J., Spear, P.G., Eisenberg, R.J., and Cohen, G.H. (1999). The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC. J. Virol. 73, 8127-8137.
26. Kurt-Jones, E.A., Chan, M., Zhou, S., Wang, J., Reed, G., Bronson, R., Arnold, M.M., Knipe, D.M., and Finberg, R.W. (2004).
27. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U.S.A. 101, 1315-1320.
28. Kwon, B.S., Tan, K.B., Ni, J., Oh, K.O., Lee, Z.H., Kim, K.K., Kim, Y.J., Wang, S., Gentz, R., Yu, G.L., Harrop, J., Lyn, S.D., Silverman, C., Porter, T.G., Truneh, A., and Young, P.R. (1997). A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 272, 14272-14276.
29. Lacor, P.N., Buniel, M.C., Chang, L., Fernandez, S.J., Gong, Y., Viola, K.L., Lambert, M.P., Velasco, P.T., Bigio, E.H., Finch, C.E., Krafft, G.A., and Klein, W.L. (2004). Synaptic targeting by Alzheimer's-related amyloid β oligomers. J. Neurosci. 24, 10191-10200.
30. Lesne, S., Koh, M.T., Kotilinek, L., Kayed, R., Glabe, C.G., Yang, A., Gallagher, M., and Ashe, K.H. (2006). A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352-357.
31. Lubinski, J.M., Wang, L., Soulika, A.M., Burger, R., Wetsel, R.A., Colten, H., Cohen, G.H., Eisenberg, R.J., Lambris, J.D., and Friedman, H.M. (1998). Herpes simplex virus type 1 glycoproteingC mediates immune evasion in vivo.J. Virol. 72, 8257-8263.
32. Lund, J., Sato, A., Akira, S., Medzhitov, R., and Iwasaki, A. (2003). Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198, 513-520.
33. Marconi, P., Krisky, D., Oligino, T., Poliani, P.L., Ramakrishnan, R., Goins, W.F., Fink, D.J., and Glorioso, J.C. (1996). Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc. Natl. Acad. Sci. U.S.A. 93, 11319-11320.
34. McGeoch, D.J., Dalrymple, M.A., Davison, A.J., Dolan, A., Frame, M.C., McNab, D., Perry, L.J., Scott, J.E., and Taylor, P. (1988). The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69, 1531-1574.
35. Meignier, B., Longnecker, R., and Roizman, B. (1988). In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: Construction and evaluation in rodents. J. Infect. Dis. 158, 602-614.
36. Melchjorsen, J., Siren, J., Julkunen, I., Paludan, S.R., and Matikainen, S. (2006). Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-κ B and IRF-3. J. Gen. Virol. 87, 1099-1108.
37. Mellerick, D.M., and Fraser, N.W. (1987). Physical state of the latent herpes simplex virus genome in a mouse model system: Evidence suggesting an episomal state. Virology 158, 265-275.
38. Mettenleiter, T.C. (2003). Pathogenesis of neurotropic herpesviruses: Role of viral glycoproteins in neuroinvasion and transneuronal spread. Virus Res. 92, 197-206.
39. Montgomery, R.I., Warner, M.S., Lum, B.J., and Spear, P.G. (1996). Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87, 427-436.
40. Newcomb, W.W., Homa, F.L., Thomsen, D.R., Trus, B.L., Cheng, N., Steven, A., Booy, F., and Brown, J.C. (1999). Assembly of the herpes simplex virus procapsid from purified components and identification of small complexes containing the major capsid and scaffolding proteins. J. Virol. 73, 4239-4250.
41. Nicola, A.V., Ponce de Leon, M., Xu, R., Hou, W., Whitbeck, J.C., Krummenacher, C., Montgomery, R.I., Spear, P.G., Eisenberg, R.J., and Cohen, G.H. (1998). Monoclonal antibodies to distinct sites on herpes simplex (HSV) glycoprotein D block HSV binding to HVEM. J. Virol. 72, 3595-3601.
42. Nicoll, J.A., Wilkinson, D., Holmes, C., Steart, P., Markham, H., and Weller, R.O. (2003). Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: A case report. Nat. Med. 9, 448-452.
43. Ojala, P.M., Sodeik, B., Ebersold, M.W., Kutay, U., and Helenius, A. (2000). Herpes simplex virus type 1 entry into host cells: Reconstitution of capsid binding and uncoating at the nuclear pore complex in vitro. Mol. Cell. Biol. 20, 4922-4931.
44. Olschowka, J.A., Bowers, W.J., Hurley, S.D., Mastrangelo, M.A., and Federoff, H.J. (2003). Helper-free HSV-1 amplicons elicit a markedly less robust innate immune response in the CNS. Mol. Ther. 7, 218-227.
45. Post, L.E., and Roizman, B. (1981). A generalized technique for deletion of specific genes in large genomes: α gene 22 of herpes simplex virus 1 is not essential for growth. Cell 25, 227-232.
46. Post, L.E., Mackem, S., and Roizman, B. (1981). Regulation of α genes of herpes simplex virus: Expression of chimeric genes produced by fusion of thymidine kinase with α gene promoters. Cell 24, 555-565.
47. Roizman, B., and Jenkins, F.J. (1985). Genetic engineering of novel genomes of large DNA viruses. Science 229, 1208-1214.
48. Sacks, W.R., Greene, C.C., Aschman, D.P., and Schaffer, P.A. (1985). Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J. Virol. 55, 796-805.
49. Saeki, Y., Ichikawa, T., Saeki, A., Chiocca, E.A., Tobler, K., Ackermann, M., Breakefield, X.O., and Fraefel, C. (1998). Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: Rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum. Gene Ther. 9, 2787-2794.
50. Saeki, Y., Fraefel, C., Ichikawa, T., Breakefield, X.O., and Chiocca, E.A. (2001). Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol. Ther. 3, 591-601.
51. Samaniego, L.A., Neiderhiser, L., and DeLuca, N.A. (1998). Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72, 3307-3320.
52. Shieh, M.T., WuDunn, D., Montgomery, R.I., Esko, J.D., and Spear, P.G. (1992). Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116, 1273-1281.
53. Shih, M.F., Arsenakis, M., Tiollais, P., and Roizman, B. (1984). Expression of hepatitis B virus S gene by herpes simplex virus type 1 vectors carrying α- and β-regulated gene chimeras. Proc. Natl. Acad. Sci. U.S.A. 81, 5867-5870.
54. Sodeik, B., Ebersold, M.W., and Helenius, A. (1997). Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus. J. Cell Biol. 136, 1007-1021.
55. Spaete, R.R., and Frenkel, N. (1982). The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector. Cell 30, 295-304.
56. Spear, P. (1993). Entry of alphaherpesviruses into cells. Semin. Virol. 4, 167-180.
57. Spear, P.G. (2004). Herpes simplex virus: Receptors and ligands for cell entry. Cell Microbiol. 6, 401-410.
58. Stavropoulos, T.A., and Strathdee, C.A. (1998). An enhanced packaging system for helper-dependent herpes simplex virus vectors. J. Virol. 72, 7137-7143.
59. Steven, A.C., and Spear, P.G. (1997). Herpesvirus capsid assembly and envelopment. In Structural Biology of Viruses. W.B. Chiu and R. Garcea, eds. (Oxford University Press, New York), pp. 312-351.
60. Stevens, J.G., Wagner, E.K., Devi-Rao, G.B., Cook, M.L., and Feldman, L.T. (1987). RNA complementary to a herpesvirus a gene mRNA is predominant in latently infected neurons. Science 235, 1056-1059.
61. Tal-Singer, R., Peng, C., Ponce De Leon, M., Abrams, W.R., Ban-field, B.W., Tufaro, F., Cohen, G.H., and Eisenberg, R.J. (1995). Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J. Virol. 69, 4471-4483.
62. Tomazin, R., Hill, A.B., Jugovic, P., York, I., van Endert, P., Ploegh, H.L., Andrews, D.W., and Johnson, D.C. (1996). Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J. 15, 3256-3266.
63. Wadsworth, S., Jacob, R.J., and Roizman, B. (1975). Anatomy of herpes simplex virus DNA. II. Size, composition, and arrangement of inverted terminal repetitions. J. Virol. 15, 1487-1497.
64. Warner, M.S., Geraghty, R.J., Martinez, W.M., Montgomery, R.I., Whitbeck, J.C., Xu, R., Eisenberg, R.J., Cohen, G.H., and Spear, P.G. (1998). A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246, 179-189.
65. Wood, M.J.A., Byrnes, A.P., Pfaff, D.W., Rabkin, S.D., and Charlton, H.M. (1994). Inflammatory effects of gene transfer into the CNS with defective HSV vectors. Gene Ther.1, 283-291.
66. WuDunn, D., and Spear, P.G. (1989). Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63, 52-58.